Pentraxin 3 levels in psoriasis, their relationship with disease severity and the efficacy of narrow-band ultraviolet B therapy


Zorlu T., Kavala M., Zindanci I., Duran S., Kuru B. C. , Turkoglu Z.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, vol.49, no.4, pp.263-265, 2015 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 4
  • Publication Date: 2015
  • Doi Number: 10.4274/turkderm.94468
  • Journal Name: TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
  • Journal Indexes: Emerging Sources Citation Index, Scopus
  • Page Numbers: pp.263-265

Abstract

Background and Design: Pentraxin 3 (PTX 3), an acute phase protein, plays an important role in activation of innate immunity and in the regulation of inflammatory reactions. Thus, considering the importance of PTX 3 in immune and inflammatory responses, it has been suggested that PTX 3 may play a role in the pathogenesis of psoriasis. The aim of this study was to evaluate plasma PTX 3 levels in patients with psoriasis and their relationship with the disease severity and the effect of narrowband ultraviolet B (nbUVB) therapy on PTX 3 levels.